|
Lipids
Citations 151-160 of 397 total displayed.
|
Past content
(since Feb 1999):
|
- Surgery for Coronary Artery Disease
Statins Are Associated With a Reduced Incidence of Perioperative Mortality After Coronary Artery Bypass Graft Surgery
- Wei Pan, Tatjana Pintar, James Anton, Vei-Vei Lee, William K. Vaughn, and Charles D. Collard
Circulation 2004;110:II-45-49II-, doi:10.1161/01.CIR.0000138316.24048.08
[Abstract]
[Full text]
- Cardiology Patient Pages
Measurement of Cholesterol: A Patient Perspective
- Kim K. Birtcher and Christie M. Ballantyne
Circulation 2004;110:e296-297e, doi:10.1161/01.CIR.0000141564.89465.4E
[Full text]
- Coronary Heart Disease
High-Dose Atorvastatin Reduces Total Plasma Levels of Oxidized Phospholipids and Immune Complexes Present on Apolipoprotein B-100 in Patients With Acute Coronary Syndromes in the MIRACL Trial
- Sotirios Tsimikas, Joseph L. Witztum, Elizabeth R. Miller, William J. Sasiela, Michael Szarek, Anders G. Olsson, Gregory G. Schwartz for the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering Study Investigators
Circulation 2004;110:1406-1412; published online before print as doi:10.1161/01.CIR.0000141728.23033.B5
[Abstract]
[Full text]
- Articles
High-Dose Atorvastatin Reduces Total Plasma Levels of Oxidized Phospholipids and Immune Complexes Present on Apolipoprotein B-100 in Patients With Acute Coronary Syndromes in the MIRACL Trial
- Sotirios Tsimikas, Joseph L. Witztum, Elizabeth R. Miller, William J. Sasiela, Michael Szarek, Anders G. Olsson, Gregory G. Schwartz for the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators
Circulation published September 7, 2004, doi:10.1161/01.CIR.0000141728.23033.B5
[Abstract]
- New Drugs and Technologies
Update on Statins: 2003
- Carl J. Vaughan and Antonio M. Gotto, Jr
Circulation 2004;110:886-892, doi:10.1161/01.CIR.0000139312.10076.BA
[Full text]
- Correspondence
Metabolic Syndrome: A Definition in Progress • Response
- Hoong Sern Lim, Jeetesh V. Patel, Gregory Y.H. Lip, and Scott M. Grundy
Circulation 2004;110:e35, doi:10.1161/01.CIR.0000139383.19636.D6
[Full text]
- Heart Failure
Acyl-Coenzyme A:Cholesterol Acyltransferase Inhibition Ameliorates Proteinuria, Hyperlipidemia, Lecithin-Cholesterol Acyltransferase, SRB-1, and Low-Denisty Lipoprotein Receptor Deficiencies in Nephrotic Syndrome
- N.D. Vaziri and K.H. Liang
Circulation 2004;110:419-425; published online before print as doi:10.1161/01.CIR.0000136023.70841.0F
[Abstract]
[Full text]
- Articles
Acyl-Coenzyme A:Cholesterol Acyltransferase Inhibition Ameliorates Proteinuria, Hyperlipidemia, Lecithin-Cholesterol Acyltransferase, SRB-1, and Low-Denisty Lipoprotein Receptor Deficiencies in Nephrotic Syndrome
- N. D. Vaziri and K. H. Liang
Circulation published July 19, 2004, doi:10.1161/01.CIR.0000136023.70841.0F
[Abstract]
- Vascular Biology
Postmenopausal Hormone Therapy Is Associated With Atherosclerosis Progression in Women With Abnormal Glucose Tolerance
- Barbara V. Howard, Judith Hsia, Pamela Ouyang, Lucy Van Voorhees, Joseph Lindsay, Angela Silverman, Edwin L. Alderman, Mark Tripputi, and David D. Waters
Circulation 2004;110:201-206; published online before print as doi:10.1161/01.CIR.0000134955.93951.D5
[Abstract]
[Full text]
- Reviews: Current Perspectives
Principles for National and Regional Guidelines on Cardiovascular Disease Prevention: A Scientific Statement From the World Heart and Stroke Forum
- Sidney C. Smith, Jr, Rod Jackson, Thomas A. Pearson, Valentin Fuster, Salim Yusuf, Ole Faergeman, David A. Wood, Michael Alderman, John Horgan, Philip Home, Marilyn Hunn, and Scott M. Grundy
Circulation 2004;109:3112-3121, doi:10.1161/01.CIR.0000133427.35111.67
[Full text]
|
|
